AlphaMark Advisors’s Parnell Pharmaceuticals Holdings Ltd PARN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-400
| Closed | – | – | 598 |
|
|
2020
Q2 | $0 | Hold |
400
| – | – | ﹤0.01% | 655 |
|
|
2020
Q1 | $0 | Hold |
400
| – | – | ﹤0.01% | 643 |
|
|
2019
Q4 | $0 | Hold |
400
| – | – | ﹤0.01% | 538 |
|
|
2019
Q3 | $0 | Hold |
400
| – | – | ﹤0.01% | 540 |
|
|
2019
Q2 | $0 | Hold |
400
| – | – | ﹤0.01% | 545 |
|
|
2019
Q1 | $0 | Buy |
+400
| New | – | ﹤0.01% | 535 |
|
|
2018
Q4 | – | Sell |
-400
| Closed | – | – | 545 |
|
|
2018
Q3 | $0 | Hold |
400
| – | – | ﹤0.01% | 562 |
|
|
2018
Q2 | $0 | Buy |
+400
| New | – | ﹤0.01% | 560 |
|
|
2018
Q1 | – | Sell |
-400
| Closed | – | – | 548 |
|
|
2017
Q4 | $0 | Hold |
400
| – | – | ﹤0.01% | 539 |
|
|
2017
Q3 | $0 | Hold |
400
| – | – | ﹤0.01% | 574 |
|
|
2017
Q2 | $0 | Hold |
400
| – | – | ﹤0.01% | 573 |
|
|
2017
Q1 | $0 | Hold |
400
| – | – | ﹤0.01% | 537 |
|
|
2016
Q4 | $0 | Hold |
400
| – | – | ﹤0.01% | 489 |
|
|
2016
Q3 | $1K | Hold |
400
| – | – | ﹤0.01% | 338 |
|
|
2016
Q2 | $1K | Sell |
400
-400
| -50% | -$1K | ﹤0.01% | 331 |
|
|
2016
Q1 | $2K | Hold |
800
| – | – | ﹤0.01% | 301 |
|
|
2015
Q4 | $3K | Buy |
+800
| New | +$3K | ﹤0.01% | 282 |
|